Monash’s CEO said the company would be happy to talk to firms about a takeover but said the stability of ownership had been a plus for recruitment.
Five months ago IVF player Virtus Health was an unloved stock but now it’s become one of the most fiercely contested takeover battles in recent memory. The main reason - it’s cheap.
Australian venture capital firm BGH has made the rare step of offering Virtus investors cash for their shares today in an off-market takeover bid.
The Australian IVF operator has sealed a takeover deal with UK-based private equity firm CapVest after a bidding war with local investor BGH Capital.
The ASX-listed IVF operator has managed to eke out a profit for fiscal 2020 despite the COVID-19 pandemic putting the brakes on elective surgeries.
Fertility treatments have been hit hard in the coronavirus crisis,but operators say they are finding a way through the patient backlog.
Melbourne “baby whisperer” Lynn Burmeister has a pink-infused and hyper-femme game plan to shake up Australia’s $550 million IVF industry. But not everyone’s tickled pink.